{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:12:34Z","timestamp":1788408754235,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.resinv.2021.05.012","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T12:27:19Z","timestamp":1624537639000},"page":"576-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chondroitin sulfate in tissue remodeling: Therapeutic implications for pulmonary fibrosis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-5176","authenticated-orcid":false,"given":"Yoshiro","family":"Kai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2021.05.012_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0022-2019","article-title":"Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis","volume":"28","author":"Collins","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2021.05.012_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0021-2019","article-title":"The therapy of idiopathic pulmonary fibrosis: what is next?","volume":"28","author":"Somogyi","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2021.05.012_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14728222.2019.1552262","article-title":"New therapeutics based on emerging concepts in pulmonary fibrosis","volume":"23","author":"Sontake","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.resinv.2021.05.012_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2021.05.012_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","article-title":"Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"17","author":"Pardo","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-\u03b2-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.resinv.2021.05.012_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-016-0328-5","article-title":"Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis","volume":"17","author":"Lehtonen","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1465-9921-15-16","article-title":"Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis","volume":"15","author":"Inomata","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1183\/09031936.04.00120803","article-title":"Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis","volume":"24","author":"Kakugawa","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2021.05.012_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(24)38125-X","article-title":"Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"289","author":"Iyer","year":"1999","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.resinv.2021.05.012_bib14","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: triple\u00a0angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Canc Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.resinv.2021.05.012_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12931-017-0654-2","article-title":"Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity","volume":"18","author":"Sato","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2017.07.062","article-title":"Therapeutic targets in idiopathic pulmonary fibrosis","volume":"131","author":"Kolb","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1165\/rcmb.2011-0158OC","article-title":"Development and preclinical efficacy of novel transforming growth factor-beta 1 short interfering RNAs for pulmonary fibrosis","volume":"46","author":"D'Alessandro-Gabazza","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/art.33482","article-title":"Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation","volume":"64","author":"Lagares","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2021.05.012_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1165\/rcmb.2011-0139OC","article-title":"Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis","volume":"46","author":"Huang","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/thx.2009.119974","article-title":"Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis","volume":"65","author":"Senoo","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2021.05.012_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/aps.2012.39","article-title":"siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats","volume":"33","author":"Zhang","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.resinv.2021.05.012_bib24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.200706-805OC","article-title":"Partial inhibition of integrin alpha(v)beta 6 prevents pulmonary fibrosis without exacerbating inflammation","volume":"177","author":"Horan","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib26","first-page":"653","volume":"vol. 11","author":"Kim","year":"2020"},{"key":"10.1016\/j.resinv.2021.05.012_bib27","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.179.6.4035","article-title":"Reduction of bleomycin-induced pulmonary\u00a0fibrosis by serum amyloid P","volume":"179","author":"Pilling","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2021.05.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009683","article-title":"Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages","volume":"5","author":"Murray","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2021.05.012_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","article-title":"TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P","volume":"43","author":"Murray","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00850-2015","article-title":"Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy","volume":"47","author":"van den Blink","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2021.05.012_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets","volume":"10","author":"Jun","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.resinv.2021.05.012_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12079-019-00542-6","article-title":"Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosis","volume":"13","author":"Leask","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.resinv.2021.05.012_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajpath.2018.01.009","article-title":"A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84","volume":"188","author":"Gagnon","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.resinv.2021.05.012_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00663-2018","article-title":"Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis","volume":"53","author":"Khalil","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2021.05.012_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2008.06.005","article-title":"Two pathways for lysophosphatidic acid production","volume":"1781","author":"Aoki","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.resinv.2021.05.012_bib36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000422","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2021.05.012_bib38","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI118612","article-title":"Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis","volume":"97","author":"Wilborn","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2021.05.012_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00228-018-2435-3","article-title":"Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin \u03b1v\u03b26 inhibitor, in healthy participants","volume":"74","author":"Maden","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.resinv.2021.05.012_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2015-207429","article-title":"Exploration of a potent PI3 kinase\/mTOR inhibitor as a novel anti-fibrotic agent in IPF","volume":"71","author":"Mercer","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2021.05.012_bib41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis,\u00a0etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.resinv.2021.05.012_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.matbio.2018.03.012","article-title":"Matrix remodeling in chronic lung diseases","volume":"73","author":"Gu","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib44","first-page":"148","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis","volume":"20","author":"Organ","year":"2019","journal-title":"cohort"},{"key":"10.1016\/j.resinv.2021.05.012_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10719-012-9463-5","article-title":"Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines","volume":"30","author":"Mizumoto","year":"2013","journal-title":"Glycoconj J"},{"key":"10.1016\/j.resinv.2021.05.012_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.sbi.2015.06.004","article-title":"Molecular interactions between chondroitin-dermatan sulfate and growth factors\/receptors\/matrix proteins","volume":"34","author":"Mizumoto","year":"2015","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.sbi.2003.09.011","article-title":"Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate","volume":"13","author":"Sugahara","year":"2003","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157016308786733564","article-title":"Potential therapeutic application of chondroitin sulfate\/dermatan sulfate","volume":"5","author":"Yamada","year":"2008","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.resinv.2021.05.012_bib49","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI116631","article-title":"Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats","volume":"92","author":"Westergren-Thorsson","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2021.05.012_bib50","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1164\/ajrccm.154.6.8970376","article-title":"Proteoglycan deposition in pulmonary fibrosis","volume":"154","author":"Bensadoun","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1843.2012.02272.x","article-title":"Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia","volume":"18","author":"Harada","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.05.012_bib52","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1164\/ajrccm.161.6.9909098","article-title":"Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats","volume":"161","author":"Venkatesan","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib53","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1164\/ajrccm.162.4.9912011","article-title":"Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects","volume":"162","author":"Ebihara","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2021.05.012_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BJ20041206","article-title":"Human xylosyltransferase I: functional\u00a0and\u00a0biochemical characterization of cysteine residues required for enzymic activity","volume":"386","author":"M\u00fcller","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.resinv.2021.05.012_bib55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1523-1747.1999.00590.x","article-title":"Serum xylosyltransferase: a\u00a0new\u00a0biochemical marker of the sclerotic process\u00a0in\u00a0systemic sclerosis","volume":"112","author":"G\u00f6tting","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.resinv.2021.05.012_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2009.09.013","article-title":"Increased serum xylosyltransferase activity in patients with liver fibrosis","volume":"409","author":"Kuhn","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.resinv.2021.05.012_bib57","doi-asserted-by":"crossref","first-page":"26441","DOI":"10.1074\/jbc.M702299200","article-title":"Transforming growth factor beta 1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling","volume":"282","author":"Prante","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1165\/rcmb.2012-0226OC","article-title":"Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-beta 1-induced pulmonary fibrosis","volume":"50","author":"Venkatesan","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib59","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1038\/s41598-018-36217-2","article-title":"microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway","volume":"8","author":"Riedel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2021.05.012_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146499","article-title":"Targeting of proteoglycan synthesis pathway: a new strategy to counteract excessive matrix proteoglycan deposition and transforming growth factor-\u03b21-induced fibrotic phenotype in lung fibroblasts","volume":"11","author":"Shaukat","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2021.05.012_bib61","doi-asserted-by":"crossref","first-page":"L191","DOI":"10.1152\/ajplung.00214.2010","article-title":"Increased deposition of chondroitin\/dermatan sulfate\u00a0glycosaminoglycan and upregulation of beta 1,3-glucuronosyltransferase I in pulmonary fibrosis","volume":"300","author":"Venkatesan","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2021.05.012_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.omtn.2016.12.008","article-title":"Silencing of carbohydrate sulfotransferase 15 hinders murine pulmonary fibrosis development","volume":"6","author":"Kai","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.resinv.2021.05.012_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142981","article-title":"Inhibition of cell proliferation and growth of pancreatic cancer by silencing of carbohydrate sulfotransferase 15 in\u00a0vitro and in a xenograft model","volume":"10","author":"Takakura","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2021.05.012_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00795-007-0370-y","article-title":"Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis","volume":"40","author":"Kai","year":"2007","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.resinv.2021.05.012_bib65","doi-asserted-by":"crossref","first-page":"10953","DOI":"10.1074\/jbc.R112.437038","article-title":"Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans","volume":"288","author":"Mizumoto","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib66","doi-asserted-by":"crossref","first-page":"495764","DOI":"10.1155\/2014\/495764","article-title":"Human genetic disorders and knockout mice deficient in glycosaminoglycan","volume":"2014","author":"Mizumoto","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.resinv.2021.05.012_bib67","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/febs.14984","article-title":"Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view","volume":"286","author":"Paganini","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.resinv.2021.05.012_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158967","article-title":"Pivotal role of carbohydrate sulfotransferase 15 in fibrosis and mucosal healing in mouse colitis","volume":"11","author":"Suzuki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2021.05.012_bib69","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01805-2016","article-title":"The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease","volume":"50","author":"Burgstaller","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2021.05.012_bib70","doi-asserted-by":"crossref","first-page":"14224","DOI":"10.1074\/jbc.M510690200","article-title":"Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II","volume":"281","author":"Schon","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.a.20440","article-title":"Desbuquois dysplasia, a reevaluation with abnormal and \"normal\" hands: radiographic manifestations","volume":"124a","author":"Faivre","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-013-1351-y","article-title":"The missing \"link\": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation","volume":"133","author":"Schreml","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib73","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/jmbi.2000.4261","article-title":"Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase\u00a0and its first isoform XT-II","volume":"304","author":"Gotting","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib74","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1074\/jbc.M611665200","article-title":"Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans","volume":"282","author":"Ponighaus","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib75","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ajhg.2015.04.017","article-title":"Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects","volume":"96","author":"Munns","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib76","doi-asserted-by":"crossref","first-page":"26165","DOI":"10.1074\/jbc.274.37.26165","article-title":"Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta 1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family","volume":"274","author":"Almeida","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib77","doi-asserted-by":"crossref","first-page":"22915","DOI":"10.1074\/jbc.274.33.22915","article-title":"Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans","volume":"274","author":"Okajima","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib78","doi-asserted-by":"crossref","first-page":"31963","DOI":"10.1074\/jbc.M113.509984","article-title":"Crystal structures of beta-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding","volume":"288","author":"Tsutsui","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib79","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.87.4.1342","article-title":"A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome","volume":"87","author":"Quentin","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2021.05.012_bib80","doi-asserted-by":"crossref","first-page":"28841","DOI":"10.1074\/jbc.274.41.28841","article-title":"Molecular basis for the progeroid variant of Ehlers-Danlos syndrome.\u00a0Identification and characterization of two mutations in galactosyltransferase I gene","volume":"274","author":"Okajima","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ejhg.2014.60","article-title":"Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome","volume":"23","author":"Cartault","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib82","doi-asserted-by":"crossref","first-page":"48189","DOI":"10.1074\/jbc.M107339200","article-title":"Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6)","volume":"276","author":"Bai","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib83","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajhg.2013.04.003","article-title":"Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders","volume":"92","author":"Nakajima","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib84","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajhg.2013.04.016","article-title":"Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder","volume":"92","author":"Malfait","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib85","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1093\/hmg\/ddy234","article-title":"Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome","volume":"27","author":"Van Damme","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib86","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1074\/jbc.273.12.6615","article-title":"Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans","volume":"273","author":"Kitagawa","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib87","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1074\/jbc.M113.520536","article-title":"Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans","volume":"289","author":"Koike","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajhg.2011.05.021","article-title":"Faulty initiation of proteoglycan synthesis causes cardiac and joint defects","volume":"89","author":"Baasanjav","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib89","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00439-015-1549-2","article-title":"Skeletal dysplasia in a consanguineous clan from the island of Nias\/Indonesia is caused by a novel mutation in B3GAT3","volume":"134","author":"Budde","year":"2015","journal-title":"Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib90","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1074\/jbc.M111434200","article-title":"Molecular cloning and expression of human chondroitin N-acetylgalactosaminyltransferase: the key enzyme for chain initiation and elongation of chondroitin\/dermatan sulfate on the protein linkage region tetrasaccharide shared by heparin\/heparan sulfate","volume":"277","author":"Uyama","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib91","doi-asserted-by":"crossref","first-page":"38189","DOI":"10.1074\/jbc.M203619200","article-title":"Enzymatic synthesis of chondroitin with a novel chondroitin sulfate N-acetylgalactosaminyltransferase that transfers N-acetylgalactosamine to glucuronic acid in initiation and elongation of chondroitin sulfate synthesis","volume":"277","author":"Gotoh","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib92","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.M208886200","article-title":"Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and elongation in synthesis of chondroitin sulfate","volume":"278","author":"Sato","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib93","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1074\/jbc.M606870200","article-title":"Chondroitin sulfate N-acetylgalactosaminyltransferase-1 plays a critical role in chondroitin sulfate synthesis in cartilage","volume":"282","author":"Sakai","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/jhg.2010.148","article-title":"Chondroitin beta-1,4-N-acetylgalactosaminyltransferase-1 missense mutations are associated with neuropathies","volume":"56","author":"Saigoh","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/humu.23070","article-title":"Chondroitin sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) deficiency results in a mild skeletal dysplasia and joint laxity","volume":"38","author":"Vodopiutz","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.resinv.2021.05.012_bib96","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1074\/jbc.M209446200","article-title":"Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin\/dermatan sulfate","volume":"278","author":"Uyama","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib97","doi-asserted-by":"crossref","first-page":"38721","DOI":"10.1074\/jbc.M106871200","article-title":"Molecular cloning and expression of a human chondroitin synthase","volume":"276","author":"Kitagawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib98","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajhg.2010.10.003","article-title":"Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in chondroitin synthase 1, a potential target of BMP signaling","volume":"87","author":"Li","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib99","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ajhg.2010.11.005","article-title":"Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic brachydactyly in humans via increased NOTCH signaling","volume":"87","author":"Tian","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib100","doi-asserted-by":"crossref","first-page":"39711","DOI":"10.1074\/jbc.M304421200","article-title":"Chondroitin sulfate synthase-3. Molecular cloning and characterization","volume":"278","author":"Yada","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib101","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1074\/jbc.M707549200","article-title":"Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members","volume":"283","author":"Izumikawa","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BJ20061876","article-title":"Involvement of chondroitin sulfate synthase-3 (chondroitin\u00a0synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor","volume":"403","author":"Izumikawa","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.resinv.2021.05.012_bib103","doi-asserted-by":"crossref","first-page":"23666","DOI":"10.1074\/jbc.M302493200","article-title":"Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization","volume":"278","author":"Kitagawa","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib104","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1074\/jbc.M303657200","article-title":"Chondroitin sulfate synthase-2. Molecular cloning and characterization of a novel human glycosyltransferase homologous to chondroitin sulfate glucuronyltransferase, which has dual enzymatic activities","volume":"278","author":"Yada","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/oxfordjournals.jbchem.a022813","article-title":"Molecular cloning, expression, and chromosomal mapping of human chondroitin 4-sulfotransferase, whose expression pattern in human tissues is different from that of chondroitin 6-sulfotransferase","volume":"128","author":"Okuda","year":"2000","journal-title":"J Biochem"},{"key":"10.1016\/j.resinv.2021.05.012_bib106","doi-asserted-by":"crossref","first-page":"20188","DOI":"10.1074\/jbc.M002443200","article-title":"Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family","volume":"275","author":"Hiraoka","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/glycob\/10.2.203","article-title":"Sulfation of sialyl N-acetyllactosamine oligosaccharides and fetuin oligosaccharides by keratan sulfate Gal-6-sulfotransferase","volume":"10","author":"Torii","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.resinv.2021.05.012_bib108","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1083\/jcb.145.4.899","article-title":"Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin","volume":"145","author":"Bistrup","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.resinv.2021.05.012_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-4781(98)00089-X","article-title":"Molecular cloning and expression of human chondroitin 6-sulfotransferase","volume":"1399","author":"Fukuta","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.resinv.2021.05.012_bib110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-5793(98)01532-4","article-title":"Functional expression and genomic structure of human chondroitin 6-sulfotransferase","volume":"441","author":"Tsutsumi","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.resinv.2021.05.012_bib111","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1073\/pnas.0400334101","article-title":"Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement","volume":"101","author":"Thiele","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2021.05.012_bib112","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.ajhg.2008.05.006","article-title":"Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis","volume":"82","author":"Hermanns","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib113","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0004.2009.01167.x","article-title":"Omani-type spondyloepiphyseal dysplasia with cardiac involvement caused by a missense mutation in CHST3","volume":"75","author":"Tuysuz","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib114","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1172\/JCI69277","article-title":"Lumbar disc degeneration is linked to a carbohydrate sulfotransferase 3 variant","volume":"123","author":"Song","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2021.05.012_bib115","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/ajmg.a.33641","article-title":"Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features","volume":"152a","author":"Unger","year":"2010","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.resinv.2021.05.012_bib116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/bbrc.2000.3141","article-title":"Diversity of N-acetylglucosamine-6-O-sulfotransferases: molecular cloning of a novel enzyme with different distribution and specificities","volume":"274","author":"Uchimura","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.resinv.2021.05.012_bib117","doi-asserted-by":"crossref","first-page":"21075","DOI":"10.1074\/jbc.M002101200","article-title":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase","volume":"275","author":"Kitagawa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib118","doi-asserted-by":"crossref","first-page":"40226","DOI":"10.1074\/jbc.M006414200","article-title":"Sulfation of N-acetylglucosamine by chondroitin 6-sulfotransferase 2 (GST-5)","volume":"275","author":"Bhakta","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib119","doi-asserted-by":"crossref","first-page":"43894","DOI":"10.1074\/jbc.M104922200","article-title":"Human N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase cDNA is related to human B cell recombination activating gene-associated gene","volume":"276","author":"Ohtake","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2021.05.012_bib120","doi-asserted-by":"crossref","first-page":"38443","DOI":"10.1074\/jbc.M306132200","article-title":"A unique nonreducing terminal modification of chondroitin sulfate by N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase","volume":"278","author":"Ohtake","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534521001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534521001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:31:26Z","timestamp":1761949886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534521001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2212534521001076"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2021.05.012","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chondroitin sulfate in tissue remodeling: Therapeutic implications for pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}